PainQx is an AI-powered medical device company developing a next-generation approach to objectively measure and monitor pain in humans.
PainQx is a diagnostic/software company that has developed a next generation approach to objectively measure pain in humans. The PainQx platform achieves this by assessing neural activity from a patient’s brain and processing and decoding the data through proprietary algorithms. The output is a scaled pain and neurological side effects biomarker that is directly correlated to a patient’s pain state. The PainQx system is currently being used as a clinical assessment tool by companies using pain as a primary or secondary clinical end point to measure their drug’s and/or device’s efficacy.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 1, 2020 | Non-Equity Assistant | — | 1 | — | — | Detail |
Aug 28, 2017 | Seed | $1.60M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Newchip | — | Non-Equity Assistant |
AJI Capital | — | Seed |